Intelligent Bio Solutions Inc. (NASDAQ: INBS) announced the results of its latest Method Comparison Study for the Intelligent Fingerprinting Drug Screening System for detection of the opiate codeine, reporting above 98% accuracy, above 94% sensitivity, and 100% specificity.

Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company that delivers intelligent, rapid, and non-invasive testing solutions. The company believes its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis. This innovative technology offers a valuable solution for employers in safety-critical industries such as construction, manufacturing, engineering, transport and logistics, mining, drug treatment organizations, coroners, and more.